MedTrace Logo

Gastrointestinal Tolerance Evaluation of an Infant Formula

NCT03307122 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2018-05-23

No results posted yet for this study

Summary

Prospective, double-blind, randomized study of 2 infant formulas.

Conditions

  • Healthy, Full-term Infants Who Are Formula-fed

Interventions

OTHER

Routine Infant Formula 1

Routine infant formula with probiotic

OTHER

Routine Infant Formula 2

Routine infant formula with probiotic and prebiotic

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Ryan Carvalho, MD · Nestle Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Days
Max Age
19 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-21
Primary Completion
2018-01-19
Completion
2018-01-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03307122 on ClinicalTrials.gov